Baton Rouge, Louisiana
7 Day Forecast
Follow our weather team on social media

Remdesivir receives FDA approval; first FDA-approved COVID-19 treatment in US

3 years 6 months 4 weeks ago Thursday, October 22 2020 Oct 22, 2020 October 22, 2020 3:33 PM October 22, 2020 in News
Source: WBRZ

BATON ROUGE - Remdesivir has received The U.S. Food and Drug Administration's approval to treat hospitalized COVID-19 patients, becoming the first FDA-approved treatment for the virus in the United States as of Thursday, Oct. 22.

Gilead Sciences' antiviral drug began being used to treat the coronavirus in May as the FDA approved it for emergency use, allowing hospitals and doctors to use the drug on hospitalized patients although it had not been formally approved.

The antiviral drug is said to stop the virus from replicating inside of the body and significantly decreases the time patients spend in the hospital, according to researchers. The drug was used to treat President Donald Trump earlier this month.

Dr. Anthony Fauci, the nation’s leading infectious disease expert, spoke highly of the treatment back in April.

"The data shows that Remdesivir has a clear-cut, significant positive effect in diminishing the time to recovery. This is really important," Dr. Fauci said.

More News

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
7 Days